| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.005 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.08 | 0.007 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.008 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.085 | 0.009 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |